Showing results (1011-1020 of 3,030) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|February 10, 2009
Potential novel targets in breast cancerPranela RameshwarCurrent Pharmaceutical Biotechnology|April 10, 2009
Regulation of cellular signal transduction pathways by the extracellular calcium-sensing receptorSarah C Brennan, Arthur D ConigraveCurrent Pharmaceutical Biotechnology|April 10, 2009
Expression and role of the calcium-sensing receptor in the blood vessel wallGuerman Molostvov, Rosemary Bland, Daniel ZehnderCurrent Pharmaceutical Biotechnology|April 10, 2009
Calcium-sensing receptor (CaSR) in human brain's pathophysiology: roles in late-onset Alzheimer's disease (LOAD)Anna Chiarini, Ilaria Dal Pra, Maddalena Marconi, et al.Current Pharmaceutical Biotechnology|April 28, 2010
3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapyS Ganapathy-Kanniappan, M Vali, R Kunjithapatham, et al.Current Pharmaceutical Biotechnology|April 28, 2010
MDMA administration and heat shock proteins response: foreseeing a molecular linkC Pomara, S D'Errico, L Zummo, et al.Current Pharmaceutical Biotechnology|April 28, 2010
The cardiovascular and cardiac actions of ecstasy and its metabolitesS K Shenouda, F Carvalho, K J VarnerCurrent Pharmaceutical Biotechnology|April 28, 2010
Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): human and animal dataEls A De Letter, Christophe P Stove, Willy E Lambert, et al.Current Pharmaceutical Biotechnology|May 28, 2010
Diffusion-weighted MRI for assessment of early cancer treatment responseStefanie Galbán, Jean-Christophe Brisset, Alnawaz Rehemtulla, et al.Current Pharmaceutical Biotechnology|November 2, 2006
New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemiaShinya Kimura, Eishi Ashihara, Taira MaekawaPageof 303